NEWS BRIEFS: GCS PR team retained by Pfizer

SAN DIEGO: GCS PR has been retained by Pfizer and Epicyte Pharmaceutical, which uses a patented technology to develop the production of human antibodies in plants for treating inflammatory and infectious diseases. The GCS team, led by Tom Gable and Jon Schmid, was retained by Pfizer to provide media relations for the May 1 opening of a new research center, Pfizer La Jolla.

SAN DIEGO: GCS PR has been retained by Pfizer and Epicyte Pharmaceutical, which uses a patented technology to develop the production of human antibodies in plants for treating inflammatory and infectious diseases. The GCS team, led by Tom Gable and Jon Schmid, was retained by Pfizer to provide media relations for the May 1 opening of a new research center, Pfizer La Jolla.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.